UVA TRANSITIONAL CARE HOSPITAL — History
CCN 492011 | 3-year financial timeline | COVID resilience: 16/100
🛡️ Public data only — no PHI permitted on this instance.
$1M
Latest Revenue (FY2022)
-72.3%
Revenue CAGR (3yr)
-74.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $13M | $9M | $1M | -89.0% | -72.3% |
| Operating Expenses | $17M | $15M | $2M | -88.8% | -68.6% |
| Operating Margin | -35.3% | -71.7% | -74.2% | -3.6% | +0.0% |
| Net Income | $-5M | $-6M | $-1M | +88.6% | +0.0% |
| Licensed Beds | 40 | 40 | 40 | +0.0% | +0.0% |
| Total Patient Days | 7,962 | 3,995 | 549 | -86.3% | -73.7% |
| Medicare Day % | 41% | 44% | 36% | -17.0% | -5.9% |
| Medicaid Day % | 5% | 1% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 16/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -92.3% ($13M → $1M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-72.3%
This Hospital
+7.6%
State Avg
Latest Margin
-74.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $-5M | -93.7% |
| FY2024 (proj) | $-11M | -113.2% |
| FY2025 (proj) | $-17M | -132.6% |